Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial

BACKGROUND: Optimal management strategies for clinically localised prostate cancer are debated. Using median 10-year data from the largest randomised controlled trial to date (ProtecT), the lifetime cost-effectiveness of three major treatments (radical radiotherapy, radical prostatectomy and active...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanghera, S., Mohiuddin, S., Coast, J., Garfield, K., Noble, S., Metcalfe, C., Lane, J. A., Turner, E. L., Neal, D., Hamdy, F. C., Martin, R. M., Donovan, J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542698/
https://www.ncbi.nlm.nih.gov/pubmed/33028256
http://dx.doi.org/10.1186/s12885-020-07276-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542698/
https://www.ncbi.nlm.nih.gov/pubmed/33028256
http://dx.doi.org/10.1186/s12885-020-07276-4

Ejemplares similares